PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-12-16 (5)

Date Title Company
16-Dec-2023 PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer Businesswire